Abstract
Brain inflammation plays a role in neurodegenerative diseases such as multiple sclerosis1 and Alzheimer’s disease (AD).2 Indeed, anti-inflammatory agents have been proposed as therapy for AD.3 The most prominent cytokine mediating inflammation is interleukin-1β (IL-1β).4 IL-1β is a product of microglia5 (the brain’s resident macrophage), and activated microglia are found in neuritic plaques in AD.6 Furthermore, IL-1β is known to stimulate the production of amyloid precursor protein,7 amyloid being a major constituent of the neuritic plaque.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
L. Steinman, Autoimmune disease, Sci. Am. September: 107 (1993).
P.L. McGeer, E.G. McGeer, T. Kawamata, T. Yamada, and H. Akiyama, Reactions of the immune system in chronic degenerative neurological diseases, Can. J. Neurol. Sci. 18: 376 (1991).
P.L. McGeer and J. Rogers, Anti-inflammatory agents as a therapeutic approach to Alzheimer’s disease, Neurol. 42: 447 (1992).
C.A. Dinarello, Interleukin 1, Rev. Infra. Dis. 6: 51 (1984).
W.S.T. Griffin, L.C. Stanley, C. Ling, L. White, V. MacLeod, U. Perrot, C.L. White, III, and C. Araoz, Brain interleukin 1 and S-100 immunoreactivity are elevated in Down Syndrome and Alzheimer disPAse, Proc. Nail Acad. Sci. USA 86: 7611 (1989).
S. Itagaki, P.L. McGeer, H. Akiyama, S. Zhu and D. Selkoe, Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease, J. Neuroimmunol. 24: 173 (1989).
D. Goldgaber, H.W. Harris, T. Hla, R. Maciag, RJ. Donnelly, J. S. Jacobsen, M.P. Vitek and D.C. Gajdusek, Interleukin 1 regulates synthesis of amyloid ß-protein precursor mRNA in human endothelial cells, Proc. Natl. Acad. Sci. USA 86: 7606 (1989).
R.A. Black, S. R. Kronheim and P.R. Sleath, Activation of interleukin-lß by a co-induced protease, FEBS Lett. 247: 336 (1989).
N.A. Thomberry, H.G. Bull, J.R. Calaycay, K.T. Chapman, A.D. Howard, M.J. Kostura, et al., A novel heterodimeric cysteine protease is required for interleukin-lß processing in monocytes, Nature (London) 356: 768 (1992).
D.P. Cerretti, C. J.Kozlosky, B. Mosley, N. Nelson, K. Van Ness, T.A. Greenstreet, C.J. March, S.R. Kronheim, R. Druck, L.A. Cannizzaro, K. Huebner, and R.A. Black, Molecular Cloning of the interleukin-lß converting enzyme, Science 256: 97 (1992).
B.D. Shivers, D.A. Giegel, and K.M. Keane, Molecular cloning of rat interleukin-lß-converting enzyme: distribution and regulation, J. Cell. Biochem. Supplement 17B:119 (1993). (accepted for Cytokine)
M.A. Nett, D.P. Cerretti, D.R. Berson, J. Seavitt, D.J. Gilbert, N.A. Jenkins, N.G. Copeland, R.A. Black, and D.D. Chaplin, Molecular cloning of the murine IL-lß converting enzyme cDNA, J. Immunol. 10: 1 (1992).
S.M. Molineaux, R.J. Casano, A.M. Rolando, E.P. Peterson, G. Limjuco, J. Chin et al., Interleukin lß(IL-l(3) processing in murine macrophages requires a structurally conserved homologue of human IL-lß converting enzyme, Proc. Natl. Acad. Sci. USA 90: 1809 (1993).
K.B. Mullis, F. Fallona, S.J. Scharf, R.K. Saiki, G. T. Horn and H.A. Erlich, Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction, Cold Spring Harbor. Quant. Biol. 51: 263 (1986).
F. Sanger, S. Nicklen, and A.R. Coulson, DNA sequencing with chain-terminating inhibitors, PrOc. Natl. Acad. Sci. USA 74: 5463 (1977).
J.J. Chirgwin, A.E. Przbyla, R. J. MacDonald, and W.J. Rutter, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochem. 18: 5294 (1979).
P.D. Walker and L.R. Carlock, Immediate-early gene activation during the intial phases of the excitotoxic cascade, J. Neurosci. Res. 36: 588 (1993).
Preparation and analysis of RNA in: “Current Protocols in Molecular Biology,” F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith and K. Stuhl, eds., Greene and Wiley Interscience, Brooklyn, NY, 1993.
D.N. Posnett and J.P. Tam, Multiple antigenic peptide method for producing antipeptide site-specific antibodies, Meth. Enzymol. 178: 739 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shivers, B.D. et al. (1995). Distribution and Regulation of Interleukin 1-β Converting Enzyme in Rat and Man. In: Hanin, I., Yoshida, M., Fisher, A. (eds) Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9145-7_35
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9145-7_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9147-1
Online ISBN: 978-1-4757-9145-7
eBook Packages: Springer Book Archive